Simon Cheesman speaks to ecancer at the 2019 Biosimilars Educational Advanced Masterclass for Pharmacists (P-BEAM) in Zurich about how real-world data generation can assist biosimilar implementation. He explains that there are potential barriers to biosimilar adoption varying from national to local.
He believes that real-world data has provided confidence that patients are not being disadvantaged by using a biosimilar.
Sign up to ecancer for free to receive tailored email alerts for more videos like this.
ecancer.org/account/register.php
0 Comments